We are delighted that, despite the Covid-19 crisis and lab lockdown, we have been able to raise over £1.3m mezzanine B2 funding for the continuation of our pioneering research on Alzheimer’s disease. We are very grateful to our existing investors for their continued...
Neuro-Bio welcomes James Barratt as part of the team. James is studying for a BSc in Pharmacology at Nottingham Trent University, and is currently working as an intern for Neuro-Bio. Neuro-Bio’s novel focus to Alzheimer’s is what encouraged him to apply, along with...
Neuro-Bio welcomes Rosie Barnett as part of the team. Rosie is currently in her third year studying pharmacology as part of her BSc sandwich course at Nottingham Trent University. She has joined the company working as an intern, to gain valuable laboratory experience...
Following our last post back in April, when we all went into lockdown, the Neuro-Bio team is very excited to be returning to the Culham offices and laboratories. The admin staff have been busy making sure our work areas comply with the covid-19 government guidelines,...
Following the government guidelines in response to covid-19 and for the safety of the team, the Culham office and laboratories are temporarily closed until the current lock-down is lifted. We are however operational from our respective bases at home: should you need...
